Arab Delegation Shows Interest in Predictive Genomic Analysis at Sbarro Health

The Arabs wink at Sport Genomics, the innovative project of predictive analysis starting from DNA. An Emirati delegation with Giampaolo Colautti, an athlete in the major international football technical teams, visits the experimental centers and research laboratories of Sbarro Health in Turin to export saliva analysis for disease prediction.

The Arabs express great interest in the innovative technologies and methodologies used in Sbarro’s laboratories to actively contribute to scientific research and the fight against diseases through funding and partnerships with excellence institutions such as Sbarro Health.

The visit paves the way for future collaborations, new research activities, and innovative projects in the field of medicine.

Antonio Giordano, president of the Sbarro Health Research Organization at Temple University, Philadelphia, enthusiastically announces the “opening of new upcoming research centers, which represent an important step forward in our mission to fight diseases and improve global health. We are convinced that scientific research and innovation are fundamental to addressing the medical challenges of the future.”

Sbarro Vice President Giancarlo Arra adds: “The research laboratories in Turin approach the most modern technologies and equipment, which will allow us to conduct high-quality studies and make significant progress in medical research. We are eager to collaborate with experts in the field and contribute to the discovery of new therapies and treatments for diseases.”

Giampaolo Colautti is impressed “by Sbarro’s vision and commitment in the field of scientific research. Preventive medicine and genetics play an increasingly important role in promoting health and preventing diseases. I am confident that the collaboration between Sbarro and experts like me can lead to positive and innovative results for the benefit of health.”

Antonio Graziano, director of Sbarro Health Italy, and Riccardo D’Aquino, Sbarro advisor, state that “new frontiers are opening up and collaboration with international partners can only benefit science and technological and sports advancement. We are already a reference point for basketball, volleyball, and football sports companies, but the type of predictive analysis implemented with genomic analyses can be extended to any type of competitive and non-competitive sports activity.”

The Sbarro Health Research Organization is increasingly at the forefront of study and research in the field of medicine, with a particular focus on genetics and disease prevention.